Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin

Ebolaviruses cause an often rapidly fatal syndrome known as Ebola virus disease (EVD), with average case fatality rates of ~50%. There is no licensed vaccine or treatment for EVD, underscoring the urgent need to develop new anti-ebolavirus agents, especially in the face of an ongoing outbreak in the...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS Negl Trop Dis
Main Authors: Covés-Datson, Evelyn M., Dyall, Julie, DeWald, Lisa Evans, King, Steven R., Dube, Derek, Legendre, Maureen, Nelson, Elizabeth, Drews, Kelly C., Gross, Robin, Gerhardt, Dawn M., Torzewski, Lisa, Postnikova, Elena, Liang, Janie Y., Ban, Bhupal, Shetty, Jagathpala, Hensley, Lisa E., Jahrling, Peter B., Olinger, Gene G., White, Judith M., Markovitz, David M.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6687191/
https://ncbi.nlm.nih.gov/pubmed/31356611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0007595
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares